United Therapeutics | UTHR - Trade Creditors


United Therapeutics reported $497.8M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Amarin USD 40.43M 21.63M Sep/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Baxter International USD 1.03B 52M Jun/2026
Bayer EUR 6.39B 192M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Gilead Sciences USD 674M 29M Jun/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
J&J USD 9.32B 94M Sep/2026
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Moderna USD 167M 6M Jun/2026
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 4.58B 75M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026